Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8083A)

TIDMHIK

RNS Number : 8083A

Hikma Pharmaceuticals Plc

25 March 2013

Hikma Pharmaceuticals PLC - Vesting of 2010 LTIP

LONDON, 25 March 2013: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received conditional share awards which vested on 23 March 2013 under the 2005 Long Term Incentive Plan ("LTIP") and were automatically exercised by operation of the conditional award and vesting process. The exercise price under the LTIP is GBPnil. The persons concerned have retained all the shares exercised.

In accordance with DTR 3.1.2R and s.793 of the Companies Act 2006, Hikma announces that the following transactions took place in London over the Company's Ordinary Shares of 10p each as detailed below.

 
 
 Bassam          Vesting of   49,476         25 March     GBP10.24   Nil       468,134 
  Kanaan          LTIP 2010                   2013 
                               (0.02% ISC)                                      (0.24% ISC) 
--------------  -----------  -------------  -----------  ---------  --------  ------------------ 
 Michael         Vesting of   44,384         25 March     GBP10.24   Nil       56,584 
  Raya            LTIP 2010                   2013 
                               (0.02% ISC)                                      (0.03% ISC) 
--------------  -----------  -------------  -----------  ---------  --------  ------------------ 
 Riad Mishlawi   Vesting of   17,660         25 March     GBP10.24   Nil       60,260 
                  LTIP 2010                   2013 
                               (0.01% ISC)                                      (0.03% ISC) 
--------------  -----------  -------------  -----------  ---------  --------  ------------------ 
 Khalid          Vesting of   23,063         25 March     GBP10.24   Nil       219,847 
  Nabilsi         LTIP 2010                   2013 
                               (0.01% ISC)                                      (0.11% ISC) 
--------------  -----------  -------------  -----------  ---------  --------  ------------------

- ENDS -

Enquiries

Peter Speirs +44 20 7399 2760

Company Secretary, Hikma Pharmaceuticals PLC

About Hikma

Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based primarily in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2012, Hikma achieved revenues of $1,108.7 million and profit attributable to shareholders of $100.3 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBSGDXGSDBGXU

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024